I'm actually surprised it isn't going up over time. That is naively what you would expect as the low-hanging fruit is plucked. So the fact that it's been stable is probably a sign that scientific advances are roughly keeping pace with the (presumably) increasing challenge of finding ever more targets for drugs.
He points out that it basically has gone up, since the 80s and 90s brought some new therapeutic targets and approaches that by now have been mined out.